Measuring body composition (fat versus lean mass) should become routine in the management of patients on GLP-1 medications. The Takeaway While GLP-1 medications are effective for weight loss, rapid weight reduction can lead to significant loss of fat-free mass, including muscle
"So, when people come off a medication that they need to treat a chronic condition -- which the conditions of overweight and obesity are -- of course, rebound weight gain is possible, if not likely." In the United States, obesity affects nearly 42% of the population and is associated with over $170 billion in medical costs, according to the Centers for Disease Control and Prevention
From June 20 to 23, 2025, the 85th Scientific Sessions of the American Diabetes Association (ADA) convened in Chicago, USA
Semaglutide GLP-1 is approved for individuals who meet specific criteria, including: If their body mass index (BMI) is 30 or greater
2 Material and methods This narrative literature review examines the use of SGLT-2 inhibitors and GLP-1 RAs in patients with T2DM and CVD
Generally, it is recommended to administer Semaglutide GLP-1 once a week, on the same day each week, and it can be taken at any time, with or without food